Maresin 1 intervention reverses experimental pulmonary arterial hypertension in mice

THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: Enzymes

(2021) Stephen PH Alexander et al.   BRITISH JOURNAL OF PHARMACOLOGY

THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: Catalytic receptors

(2021) Stephen PH Alexander et al.   BRITISH JOURNAL OF PHARMACOLOGY

THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: Introduction and Other Protein Targets

(2021) Stephen PH Alexander et al.   BRITISH JOURNAL OF PHARMACOLOGY

THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: G protein‐coupled receptors

(2021) Stephen PH Alexander et al.   BRITISH JOURNAL OF PHARMACOLOGY

Endothelial-to-Mesenchymal Transition in Pulmonary Arterial Hypertension

(2020) Anastasia Gorelova et al.   ANTIOXIDANTS & REDOX SIGNALING

ARRIVE 2.0 and the British Journal of Pharmacology: Updated guidance for 2020

(2020) Elliott Lilley et al.   BRITISH JOURNAL OF PHARMACOLOGY

The ARRIVE guidelines 2.0: Updated guidelines for reporting animal research

(2020) Nathalie Percie du Sert et al.   PLOS BIOLOGY

Niacin Attenuates Pulmonary Hypertension Through H-PGDS in Macrophages

(2020) Daile Jia et al.   CIRCULATION RESEARCH

Endothelial-to-Mesenchymal Transition and Inflammation Play Key Roles in Cyclophilin A–Induced Pulmonary Arterial Hypertension

(2020) Chao Xue et al.   HYPERTENSION

Maresin-1 and Resolvin E1 Promote Regenerative Properties of Periodontal Ligament Stem Cells Under Inflammatory Conditions

(2020) Emmanuel Albuquerque-Souza et al.   Frontiers in Immunology

Selective BMP-9 Inhibition Partially Protects Against Experimental Pulmonary Hypertension

(2019) Ly Tu et al.   CIRCULATION RESEARCH

Endothelial to Mesenchymal Transition in Cardiovascular Disease

(2019) Jason C. Kovacic et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

The specialised pro‐resolving lipid mediator maresin 1 reduces inflammatory pain with a long‐lasting analgesic effect

(2019) Victor Fattori et al.   BRITISH JOURNAL OF PHARMACOLOGY

Medical Therapy for Heart Failure Associated With Pulmonary Hypertension

(2019) Jason G.E. Zelt et al.   CIRCULATION RESEARCH

Maresin 1 activates LGR6 receptor promoting phagocyte immunoresolvent functions

(2019) Nan Chiang et al.   JOURNAL OF CLINICAL INVESTIGATION

Goals and practicalities of immunoblotting and immunohistochemistry: A guide for submission to the British Journal of Pharmacology

(2018) Steve P H Alexander et al.   BRITISH JOURNAL OF PHARMACOLOGY

Experimental design and analysis and their reporting II: updated and simplified guidance for authors and peer reviewers

(2018) Michael J Curtis et al.   BRITISH JOURNAL OF PHARMACOLOGY

STIM2 (Stromal Interaction Molecule 2)–Mediated Increase in Resting Cytosolic Free Ca2+Concentration Stimulates PASMC Proliferation in Pulmonary Arterial HypertensionNovelty and Significance

(2018) Shanshan Song et al.   HYPERTENSION

Pulmonary arterial hypertension: pathogenesis and clinical management

(2018) Thenappan Thenappan et al.   BMJ-British Medical Journal

Pulmonary arterial hypertension: pathogenesis and clinical management

(2018) Thenappan Thenappan et al.   BMJ-British Medical Journal

Maresin 1 improves the Treg/Th17 imbalance in rheumatoid arthritis through miR-21

(2018) Shengwei Jin et al.   ANNALS OF THE RHEUMATIC DISEASES

Inflammation induces endothelial-to-mesenchymal transition and promotes vascular calcification through downregulation of BMPR2

(2018) Gonzalo Sánchez-Duffhues et al.   JOURNAL OF PATHOLOGY

CrossTalk proposal: The mouse SuHx model is a good model of pulmonary arterial hypertension

(2018) Krishna C. Penumatsa et al.   JOURNAL OF PHYSIOLOGY-LONDON

Pulmonary arterial hypertension in congenital heart disease: translational opportunities to study the reversibility of pulmonary vascular disease

(2017) Diederik E. van der Feen et al.   EUROPEAN HEART JOURNAL

Posttreatment with Protectin DX ameliorates bleomycin-induced pulmonary fibrosis and lung dysfunction in mice

(2017) Hui Li et al.   Scientific Reports

Pro-resolving lipid mediators are leads for resolution physiology

(2014) Charles N. Serhan   NATURE

Pro-proliferative and inflammatory signaling converge on FoxO1 transcription factor in pulmonary hypertension

(2014) Rajkumar Savai et al.   NATURE MEDICINE

Right Heart Adaptation to Pulmonary Arterial Hypertension

(2013) Anton Vonk-Noordegraaf et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Pulmonary vascular disease in mice xenografted with human BM progenitors from patients with pulmonary arterial hypertension

(2012) K. Asosingh et al.   BLOOD

Plumbagin reverses proliferation and resistance to apoptosis in experimental PAH

(2012) Audrey Courboulin et al.   EUROPEAN RESPIRATORY JOURNAL

Macrophage proresolving mediator maresin 1 stimulates tissue regeneration and controls pain

(2012) Charles N. Serhan et al.   FASEB JOURNAL

Basic Science of Pulmonary Arterial Hypertension for Clinicians

(2010) Stephen L. Archer et al.   CIRCULATION

Reversible or Irreversible Remodeling in Pulmonary Arterial Hypertension

(2009) Seiichiro Sakao et al.   AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY

ATLa, an Aspirin-Triggered Lipoxin A4 Synthetic Analog, Prevents the Inflammatory and Fibrotic Effects of Bleomycin-Induced Pulmonary Fibrosis

(2009) V. Martins et al.   JOURNAL OF IMMUNOLOGY

Loss of PTEN attenuates the development of pathological hypertrophy and heart failure in response to biomechanical stress

(2008) G. Y. Oudit et al.   CARDIOVASCULAR RESEARCH